00:37 , May 13, 2016 |  BC Extra  |  Top Story

Ellison donates $200M to create USC cancer institute

Larry Ellison donated $200 million to the University of Southern California (Los Angeles, Calif.) to establish the Lawrence J. Ellison Institute for Transformative Medicine of USC, which aims to combine research with prevention and treatment...
07:00 , Mar 17, 2016 |  BC Innovations  |  Tools & Techniques

Gut re-action

A group of New York academics has developed a protocol to turn human pluripotent stem cells into gut neurons, and believes it could provide the first non-surgical treatment for Hirschsprung's disease - a rare disorder...
08:00 , Jan 28, 2016 |  BC Innovations  |  Product R&D

Hitchhiker's guide to the gut

Applied Molecular Transport LLC (AMT) believes it has cracked the problem of orally delivering therapeutic proteins that has been the bane of biologics from the outset. The company has co-opted a strategy and a molecule...
07:00 , Mar 9, 2015 |  BC Week In Review  |  Company News

J&J other, pharmaceuticals news

Johnson & Johnson launched the fourth incubator in its JLABS network, located in South San Francisco, and named the first 10 companies in residence. J&J said the incubator can accommodate up to 50 startups. Eight...
01:47 , Mar 4, 2015 |  BC Extra  |  Company News

J&J launches second Bay Area JLABS incubator

Johnson & Johnson (NYSE:JNJ) launched the fourth incubator in its JLABS network, located in South San Francisco, Calif., and named the first 10 companies in residence. J&J said the incubator can accommodate up to 50...
08:00 , Feb 2, 2015 |  BC Week In Review  |  Company News

Applied Molecular Transport, J&J deal

Applied Molecular Transport granted Johnson & Johnson’s Janssen Biotech Inc. unit exclusive, worldwide rights to an undisclosed preclinical oral candidate, which is in development to treat inflammatory bowel disease (IBD). Applied Molecular’s Transint technology allows...
01:39 , Jan 29, 2015 |  BC Extra  |  Company News

Applied Molecular Transport, Janssen strike IBD deal

Applied Molecular Transport LLC (South San Francisco, Calif.) granted the Janssen Biotech Inc. unit of Johnson & Johnson (NYSE:JNJ) exclusive worldwide rights to an undisclosed preclinical oral candidate to treat inflammatory bowel disease (IBD). AMT...
08:00 , Feb 13, 2014 |  BC Innovations  |  Distillery Techniques

Technology: Drug platforms

This week in techniques Approach Summary Licensing status Publication and contact information Drug platforms Systematic evolution of ligands by exponential enrichment (SELEX) incorporating artificially expanded genetic information systems (AEGIS) nucleotides SELEX using AEGIS-incorporating libraries could...
07:00 , May 21, 2012 |  BioCentury  |  Strategy

Remembrance: The Titan who changed our lives

Remembrance: The Titan who changed our lives For those of us who entered the biotech industry in the 1980s, George Rathmann already was a living legend. And those of us who knew him consider ourselves...
07:00 , Sep 23, 2010 |  BC Innovations  |  Targets & Mechanisms

Overcoming C. differences

It has been known for some time that the pathogenesis of Clostridium difficile depends on a pair of toxic proteins secreted by the bacterium. But it has been less clear which of the two toxins-toxin...